# BDTB (Bodhi Tree Biotechnology Inc.) - SEC EDGAR Financial Statements

> Bodhi Tree Biotechnology Inc. reported $37K in revenue and a net loss of $116K for the trailing twelve months ended June 30, 2026, with a -310.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/BDTB
- Markdown: https://convexityos.com/fundamentals/BDTB.md
- SEC CIK: 0002041531
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002041531&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $37K | Jun 30, 2026 |
| Operating Income | TTM | -$115K | -310.2% margin |
| Net Income | TTM | -$116K | -313.6% net margin |
| Diluted EPS | TTM | -$0.00 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | $4.0K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| **Revenue** | $17K |
| **Operating Income** | -$148K |
| Income Before Tax | -$148K |
| Income Tax Expense | $2.0K |
| **Net Income** | -$150K |
| Basic EPS | -$0.01 |
| **Diluted EPS** | -$0.01 |
| Basic Shares Outstanding | 25.4M |
| Diluted Shares Outstanding | 25.4M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10K | $15K | $0 | $12K | $0 | $0 | $5.0K | -- |
| **Operating Income** | -$23K | -$28K | -$53K | -$11K | -$20K | -$52K | -$65K | -$72K |
| Income Before Tax | -$23K | -$28K | -$53K | -$11K | -$20K | -$52K | -$65K | -- |
| Income Tax Expense | -- | $1.3K | -- | -- | $800 | $1.2K | -- | -- |
| **Net Income** | -$23K | -$29K | -$53K | -$11K | -$21K | -$53K | -$65K | -$72K |
| Basic EPS | $0.00 | $0.00 | -$0.01 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | -$0.01 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 25.4M | 25.4M | 25.4M | -- | 25.4M | 25.4M | 25.4M | -- |
| Diluted Shares Outstanding | 25.4M | 25.4M | 25.4M | -- | 25.4M | 25.4M | 25.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $109K | $260K |
| **Cash & Short-Term Investments** | $109K | $260K |
| **Total Assets** | $119K | $269K |
| **Total Current Liabilities** | -- | $500 |
| **Total Non-Current Liabilities** | -- | $0 |
| **Total Liabilities** | $0 | $500 |
| Common Stock | $2.5K | $2.5K |
| Retained Earnings | -$212K | -$62K |
| **Total Stockholders' Equity** | $119K | $269K |
| Total Equity | $119K | $269K |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.0K | $23K | $47K | $109K | $120K | $144K | $260K |
| **Cash & Short-Term Investments** | $4.0K | $23K | $47K | $109K | $120K | $144K | $260K |
| **Total Assets** | $18K | $41K | $70K | $119K | $130K | $151K | $269K |
| **Total Current Liabilities** | $4.5K | $3.5K | $3.5K | -- | -- | -- | $500 |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | -- | -- | -- | $0 |
| **Total Liabilities** | $4.5K | $3.5K | $3.5K | $0 | $0 | $0 | $500 |
| Common Stock | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K |
| Retained Earnings | -$317K | -$294K | -$265K | -$212K | -$201K | -$180K | -$62K |
| **Total Stockholders' Equity** | $14K | $37K | $66K | $119K | $130K | $151K | $269K |
| Total Equity | $14K | $37K | $66K | $119K | $130K | $151K | $269K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Net Income | -$150K |
| **Operating Cash Flow** | -$150K |
| **Net Change in Cash** | -$150K |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$23K | -$29K | -$53K | -$11K | -$21K | -$53K | -$65K | -$72K |
| **Operating Cash Flow** | -$19K | -$25K | -$62K | -$10K | -$25K | -$50K | -$65K | -$91K |
| **Financing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $281K |
| **Net Change in Cash** | -$19K | -$25K | -$62K | -$10K | -$25K | -$50K | -$65K | $190K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 |
| --- | --- |
| **Operating Margin** | -868.3% |
| **Net Profit Margin** | -880.4% |
| Return on Equity (ROE) | -125.6% |
| Return on Assets (ROA) | -125.6% |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -310.2% | -413.1% | -1131.6% | -868.3% | -- | -- | -- | -- |
| **Net Profit Margin** | -313.6% | -420.8% | -1148.6% | -880.4% | -- | -- | -- | -- |
| Return on Equity (ROE) | -839.4% | -306.9% | -208.2% | -125.6% | -162.1% | -119.5% | -- | -- |
| Return on Assets (ROA) | -633.2% | -280.4% | -197.7% | -125.6% | -162.1% | -119.5% | -- | -- |
| Quick Ratio | 0.89x | 6.50x | 13.53x | -- | -- | -- | -- | 519.14x |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | -- | -100.0% | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -305.3% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -313.5% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -227.1% | -13154.2% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
